Recruiting OBSERVATIONAL NCT04926584

Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option (KOMPASSneo)

Prospective Trial of Immunotherapy Prior to Resection, Definitive Chemo-radiotherapy, or Palliative Therapy in Patients With Locally Advanced or Oligometastatic Non-small Cell Lung Cancer Without a Primary Curative Option

Sponsor: Klinikum Esslingen

Conditions Carcinoma, Non-Small-Cell Lung

Interventions induction therapy

Updated 5 times since 2021 Last updated: Aug 15, 2022 Started: Dec 15, 2017 Primary completion: Dec 31, 2024 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04926584, this observational or N/A phase trial focuses on Carcinoma, Non-Small-Cell Lung and remains actively recruiting participants. Sponsored by Klinikum Esslingen, it has been updated 5 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Sep 2024 — Sep 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2022 — Jul 2024 [monthly]

Recruiting
Sep 2021 — Sep 2022 [monthly]

Recruiting

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Klinikum Esslingen

Data source: Klinikum Esslingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Esslingen am Neckar, Germany